Nordic Pharma Consulting ApS — Credit Rating and Financial Key Figures
CVR number: 37368598
Ullasvej 7 B, 2880 Bagsværd
bill@nordicpharmaconsulting.com
tel: 23645858
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 8 895.81 | 8 678.00 | 11 616.46 | 11 213.01 | 14 101.87 |
| Employee benefit expenses | -6 921.04 | -6 307.00 | -6 960.19 | -9 165.38 | -10 289.20 |
| EBIT | 1 974.77 | 2 371.00 | 4 656.27 | 2 047.63 | 3 812.67 |
| Other financial income | 5.11 | 3.00 | 0.69 | 8.10 | 29.14 |
| Other financial expenses | -23.19 | -30.00 | -37.22 | -1.09 | -15.90 |
| Pre-tax profit | 1 956.69 | 2 344.00 | 4 619.74 | 2 054.64 | 3 825.92 |
| Income taxes | - 437.07 | - 524.00 | -1 025.16 | - 465.81 | - 859.54 |
| Net earnings | 1 519.62 | 1 820.00 | 3 594.58 | 1 588.83 | 2 966.38 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 2 086.29 | 3 289.00 | 7 250.62 | 4 067.46 | 4 538.80 |
| Prepayments and accrued income | 97.66 | ||||
| Current other receivables | 49.71 | 109.63 | 109.63 | ||
| Short term receivables total | 2 086.29 | 3 289.00 | 7 300.33 | 4 177.09 | 4 746.09 |
| Cash and bank deposits | 2 536.34 | 1 764.00 | 2 879.73 | 1 029.78 | 3 399.42 |
| Cash and cash equivalents | 2 536.34 | 1 764.00 | 2 879.73 | 1 029.78 | 3 399.42 |
| Balance sheet total (assets) | 4 622.63 | 5 053.00 | 10 180.06 | 5 206.87 | 8 145.51 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 1 519.62 | 1 820.00 | 3 594.58 | 1 588.83 | 2 966.38 |
| Retained earnings | - 767.02 | -1 067.00 | -2 841.99 | - 836.23 | -2 213.78 |
| Profit of the financial year | 1 519.62 | 1 820.00 | 3 594.58 | 1 588.83 | 2 966.38 |
| Shareholders equity total | 2 322.21 | 2 623.00 | 4 397.18 | 2 391.43 | 3 768.97 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 12.05 | 14.00 | 40.41 | 74.17 | 37.03 |
| Current trade creditors | 35.39 | 35.00 | 1 246.02 | 347.60 | 155.97 |
| Current owed to group member | 447.47 | 895.00 | 1 438.38 | 440.54 | 795.34 |
| Short-term deferred tax liabilities | 437.07 | 524.00 | 1 025.16 | 465.81 | 859.54 |
| Other non-interest bearing current liabilities | 1 368.43 | 962.00 | 2 032.90 | 1 487.33 | 2 528.65 |
| Current liabilities total | 2 300.42 | 2 430.00 | 5 782.88 | 2 815.44 | 4 376.54 |
| Balance sheet total (liabilities) | 4 622.63 | 5 053.00 | 10 180.06 | 5 206.87 | 8 145.51 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.